European Medicines Evaluation

Related by string. * Europeans . european . EUROPEAN . europeans : European Medicines Agency . DJ Stoxx European . European #MM Put / medicines . MEDICINE . medi cine : journal Nature Medicine . Medicine Hat Tigers . Critical Care Medicine / Evaluations . evaluations . EVALUATION : undergo psychiatric evaluation . undergoing psychiatric evaluation . psychological evaluation * *

Related by context. All words. (Click for frequent words.) 74 Medicinal Products EMEA 69 European Medicines Agency 68 Human Medicinal Products 68 Human Use CHMP 67 CHMP 67 Marketing Authorization Application 67 CHMP opinion 67 Medicinal Products 65 orphan medicinal product 65 Orphan Medicinal Products 65 Orathecin 65 Orphan Medicinal Product 65 Marketing Authorization Applications 64 Adenuric R 64 FDA Oncologic Drugs 64 OMP designation 64 Marketing Authorization Application MAA 63 Marketing Authorisation Application 63 Centralized Procedure 63 Marketing Authorization 63 CHMP recommendation 63 Orphan Drug status 63 Joulferon 62 TEMODAL 62 CELVAPAN H#N# 62 Sebivo 62 Peginterferon alfa 2b 62 MAA submission 62 SYCREST 62 Application MAA 62 orphan designation 62 Marketing Authorisation 61 Romiplostim 61 Anti Infective Drugs 61 Torisel 61 mifamurtide 61 Orphan Drug designation 61 Swissmedic 61 Icatibant 61 NOXAFIL 61 Toctino R 61 methylnaltrexone bromide 61 ONGLYZA ™ 61 Raptiva R 61 Proprietary Medicinal Products 61 indiplon capsules 61 Alitretinoin 61 FIRAZYR 61 sorafenib tablets 61 Certican 61 Clofarabine 61 Cladribine 61 Fast Track Status 61 Orphan Drug designations 61 Velcade bortezomib 60 ELIQUIS 60 FDA Antiviral Drugs 60 BENLYSTA 60 Telavancin 60 JOULFERON 60 CONBRIZA 60 Increlex R 60 Clolar 60 Focetria 60 Vasovist 60 eprodisate KIACTA TM 60 supplemental Biologics License Application 60 Proprietary Medicinal Products CPMP 60 Dacogen injection 60 Rhucin ® 60 Oncologic Drugs Advisory 60 Nebido 60 Xyrem ® 60 rasagiline tablets 60 Orphan Drug Status 60 Jevtana 60 GTC recombinant form 60 Torisel temsirolimus 60 Arzerra ofatumumab 60 Somatuline Depot 60 Biologic License Application BLA 60 Orphan Status 60 alvimopan 60 Hycamtin 60 Noxafil 60 Receives Positive Opinion 59 Plicera 59 EGRIFTA TM 59 Neupro R 59 Trobalt 59 Marketing Authorisation Application MAA 59 SmPC 59 Pirfenidone 59 R sorafenib tablets 59 Mepact 59 Gleevec Glivec 59 Teysuno 59 XIAFLEX ™ 59 Nexavar ® 59 Junovan 59 Vidaza azacitidine 59 SUTENT ® 59 Cellegesic 59 Pulmonary Allergy Drugs 59 Tygacil 59 Esbriet ® 59 Pegintron 59 FDA approvable letter 59 interferon gamma 1b 59 Orapred ODT 59 OMAPRO ™ 59 Reclast Aclasta 59 Voraxaze 59 Tyverb 59 Somatuline R Autogel R 59 Onrigin 59 Velac 59 DORIBAX 59 Complete Response 59 bazedoxifene 59 Zalbin 59 Formal Dispute Resolution 59 approvable letters 59 Tasigna nilotinib 59 Raptiva ® 59 UPLYSO 59 histamine dihydrochloride 59 FDA Approvable Letter 59 TYKERB 59 Tarceva TM 59 human antithrombin 59 Esbriet pirfenidone 59 SEBIVO 59 MAGE A3 ASCI 59 Market Authorization Application 59 AMITIZA R 59 YONDELIS 59 XGEVA ™ 59 Bayer Nexavar 59 Plenaxis R 58 TRISENOX 58 Australian Therapeutic Goods 58 Nexavar sorafenib 58 sitaxsentan sodium 58 Serdolect ® 58 Eloxatin ® 58 MYLOTARG 58 Avastin bevacizumab 58 Soliris TM eculizumab 58 PLAVIX ® 58 Drug Administration Oncologic Drugs 58 Thalidomide Pharmion 58 Toctino ® alitretinoin 58 efalizumab 58 Scientific Advice 58 Preotact R 58 Hexvix 58 Fludara ® 58 Complete Response Letter CRL 58 sapropterin dihydrochloride 58 ORENCIA R 58 BLA filing 58 Zenpep 58 COLAZAL R 58 AVASTIN 58 CERVARIX R 58 Arthritis Advisory 58 Kuvan R 58 sNDA 58 Metabolic Drugs Advisory 58 Tredaptive 58 oxymorphone ER 58 refractory chronic lymphocytic 58 ONGLYZA TM 58 Egrifta 58 Removab 58 ezogabine 58 Positive Opinion 58 Rhucin R 58 FACTIVE R gemifloxacin 58 acyclovir Lauriad R 58 Rasilez HCT 58 TYZEKA 58 investigational compound 58 SNT MC# 58 Alvesco R 58 Civacir 58 Evoltra TM 58 FDA Accepts 58 Panzem R 58 Pixuvri 58 posaconazole 58 FOLOTYN ® 58 MHRA Medicines 58 Marqibo 58 Priority Review 58 ixabepilone 58 Frova ® 58 Mycamine 58 Complete Response Letter 58 AZILECT R 58 Accelerated Approval 58 submitted Marketing Authorization 58 FDA Anti Infective 58 Arzerra TM 57 Ixempra 57 ACOMPLIA R 57 Valtropin 57 Revlimid lenalidomide 57 Arranon 57 Lubiprostone 57 thetreatment 57 Aclasta 57 Biologic License Application 57 tramiprosate ALZHEMED TM 57 Proquin XR 57 Lambert Eaton Myasthenic 57 Aflibercept 57 Onsolis 57 anti inflammatory NSAID 57 Genasense ® 57 REBETOL combination therapy 57 rilonacept 57 Alimta pemetrexed 57 STELARA TM 57 albinterferon alfa 2b 57 RELISTOR ® 57 pancreatic enzyme replacement 57 sBLA 57 Preotact 57 miconazole MBT 57 Zavesca R 57 Risperidone Oral Solution 57 Vectibix panitumumab 57 Androxal ® 57 Application BLA 57 Rhucin ® recombinant 57 Nabi HB Intravenous 57 BRILINTA 57 ORENCIA ® 57 Arzerra 57 TORISEL TM 57 Ceflatonin 57 Oracea ® 57 approvability 57 Decentralized Procedure 57 Orphan Designation 57 Satraplatin 57 Anidulafungin 57 Firdapse ™ amifampridine phosphate 57 Clolar ® 57 IL# PE#QQR 57 Telzir 57 Allovectin 7 ® 57 Kristalose R 57 Revolade 57 Vandetanib 57 TYGACIL 57 forodesine 57 Antiviral Drugs Advisory 57 etanercept Enbrel 57 Angiox ® 57 CDP# 57 Brilique 57 balsalazide tablet 57 CAELYX 57 ARCOXIA 57 Evoltra ® 57 Toctino ® 57 Increlex ® 57 Fibrillex TM 57 Yondelis ® 57 Orphan Drug 57 Sprycel dasatinib 57 Focalin XR R 57 Cloretazine ® 57 Announces Tentative Approval 57 regadenoson 57 GATTEX TM 57 Evoltra 57 NEBIDO 57 REVLIMID lenalidomide 57 desvenlafaxine 57 Keppra ® levetiracetam 57 Mirapexin 57 Cancidas 57 Impax ANDA 57 AzaSite Plus 57 clofarabine 57 Promacta 57 Entocort 57 Fast Track Designation 57 Cimzia ® certolizumab pegol 57 ELACYT 57 REVLIMID R 57 YONDELIS R 57 OPAXIO 57 Sycrest 57 Tracleer r 56 dalbavancin 56 PROMACTA 56 supplemental biologics 56 Desvenlafaxine 56 Aviptadil 56 XIAFLEX TM 56 IV acetaminophen 56 Rebif ® 56 T Pred 56 Emezine 56 Barr ANDA 56 Troxatyl 56 Pivotal Phase III 56 FIRMAGON R 56 Advexin 56 Ambrisentan 56 Loramyc 56 Afatinib 56 INSPIRE Trial Phase III 56 Cimzia ® 56 VPRIV 56 BENLYSTA ® 56 Firazyr 56 RoActemra 56 intravenous acetaminophen 56 Actimmune ® 56 Therapeutic Products 56 hypereosinophilic syndrome 56 Octreolin 56 vandetanib 56 GTC recombinant human 56 Febuxostat 56 BYETTA ® 56 Product Characteristics 56 oral cladribine 56 buccal tablets 56 #D#C# 56 Modrenal R 56 guanfacine extended release 56 adalimumab Humira 56 Vernakalant 56 ABILIFY R 56 IRESSA 56 ZADAXIN ® 56 Frova R 56 BioNumerik 56 pregabalin Lyrica 56 lucinactant 56 Pentacel vaccine 56 Movectro 56 VISICOL R 56 cetuximab Erbitux 56 OLEPTRO 56 abatacept Orencia 56 Onco TCS 56 Basilea Toctino R 56 Neupro ® 56 Entereg R 56 solifenacin succinate 56 talactoferrin 56 Onbrez Breezhaler 56 neratinib 56 Arixtra 56 rotigotine transdermal patch 56 Abiraterone acetate 56 FDA Orphan Drug 56 MethyPatch 56 Drug Eluting Stent System 56 Ruconest 56 Liprotamase 56 Tysabri natalizumab 56 ZALBIN 56 5mg #mg #mg 56 Glybera R 56 Dyloject TM 56 refractory acute promyelocytic 56 Supplemental Biologics License Application 56 injectable formulations 56 sublingual tablets 56 BLA submission 56 CAMPATH R 56 Orphan Drug Designation 56 galiximab 56 Glatiramer Acetate 56 sunitinib malate 56 severe hypercholesterolemia 56 5 lipoxygenase inhibitor 56 sorafenib Nexavar 56 AstraZeneca Iressa 56 pediatric exclusivity 56 TORISEL 56 Receives Marketing Authorization 56 cinacalcet HCl 56 Aflunov 56 Taxotere docetaxel 56 Therapeutic Products Swissmedic 56 Ruconest ™ 56 Uvidem 56 Femara letrozole 56 TRISENOX ® 56 Cimzia R 56 Exalgo 56 Ticagrelor 56 Rasilamlo 56 thalidomide Thalomid 56 Replagal 56 Serdolect 56 human C1 inhibitor 56 Xarelto rivaroxaban 56 Amlodipine Besylate 56 carcinogenicity studies 56 Metformin GR 56 fluoroquinolone antibiotic 56 Luveris 56 Angiox 56 Eraxis 56 daptomycin 55 TWYNSTA ® 55 Relistor 55 Celebrex celecoxib 55 Fortigel 55 Kuvan sapropterin dihydrochloride 55 gepirone ER 55 Actemra tocilizumab 55 Clevudine 55 Plenaxis TM 55 Saphris 55 THALOMID 55 methylnaltrexone 55 Ranolazine 55 approvable letter 55 SILENOR 55 Advagraf 55 HFA MDI 55 LEVAQUIN 55 aztreonam 55 Remicade infliximab 55 ATPace TM 55 Fodosine 55 oral ridaforolimus 55 FRDA 55 aflibercept 55 docetaxel Taxotere ® 55 Mimpara 55 Extavia 55 ZEFTERA TM Zevtera TM 55 hoFH 55 Approvable Letter 55 Rhucin 55 romiplostim 55 Drug Submission 55 Ophthalmic Drugs Advisory 55 Saforis 55 Rebetol 55 Soriatane 55 Biologics License Application BLA 55 REYATAZ R 55 Fast Track designations 55 Doribax 55 Japanese Encephalitis vaccine 55 MERREM 55 Erbitux cetuximab 55 ATryn R 55 Aurexis 55 granted orphan medicinal 55 PDX pralatrexate 55 Abstral ® 55 Bonefos 55 ALVESCO R 55 virus HCV protease inhibitor 55 PROVIGIL 55 Lodotra 55 Eltrombopag 55 Amrubicin 55 FDA Endocrinologic 55 Biological License Application 55 RoACTEMRA 55 Keppra ® XR 55 levocetirizine 55 Trovax 55 octreotide acetate 55 Herceptin trastuzumab 55 pemetrexed Alimta 55 Syndrome LEMS 55 candidates Dyloject TM 55 Afinitor ® 55 Entereg 55 Ciclesonide 55 AZILECT ® 55 Orphan designation 55 eribulin mesylate 55 RhuDex ® 55 Ranexa R 55 diabetic neuropathic pain 55 Ganite R 55 Clinical Trial Application 55 Friedreich Ataxia FRDA 55 UCB Cimzia 55 THELIN 55 rheumatoid arthritis psoriatic arthritis 55 ONCASPAR 55 Muraglitazar 55 ATryn ® GTC recombinant 55 Campath ® 55 Aryplase 55 SPRYCEL ® 55 Tibotec Therapeutics division 55 Fablyn 55 Cinryze ™ 55 Ceftobiprole 55 Potiga 55 indacaterol 55 FUSILEV ® 55 Retacrit 55 THALOMID R 55 Fondaparinux 55 Orencia abatacept 55 Final Appraisal Determination 55 infusional 5-FU/LV 55 Afinitor everolimus 55 PRISTIQ 55 PegIntron 55 myelodysplastic myeloproliferative diseases 55 TELINTRA 55 highly purified pasteurized 55 Combidex 55 balsalazide 55 sNDAs 55 diabetic peripheral neuropathic pain 55 Multaq dronedarone 55 Prexige lumiracoxib 55 SCHWARZ PHARMA 55 Silodosin 55 Eucreas 55 vinflunine 55 Actemra 55 UVIDEM 55 Onglyza saxagliptin 55 Oracea TM 55 QNEXA 55 IMA# 55 Biologics Licensing 55 Taxotere ® 55 mesylate tablets 55 Rectogesic 55 atypical antipsychotic medication 55 Cerepro 55 glucocorticoid induced osteoporosis 55 donepezil rivastigmine 55 TheraCIM 55 Adentri 55 telavancin NDA 55 Rasagiline 55 eprodisate Fibrillex TM 55 Dynepo 55 CIP TRAMADOL ER 55 markets HP Acthar 55 AERIUS 55 Azacitidine 55 Cellegesic TM nitroglycerin ointment 55 orBec 55 corticotropin injection 55 pioglitazone HCl 55 sorafenib tosylate 55 Hexvix ® 55 amifampridine phosphate 55 liver resection surgeries 55 Dexilant 55 k Premarket Notification 55 MabCampath 55 investigational antiplatelet agent 55 SEROQUEL XR 55 ONGLYZA 55 NEUPREX R 55 bosutinib 55 SPARLON 55 Vertex telaprevir 55 SinuNase TM 55 Vitrasert R 55 Angiox R 55 casopitant 55 pralatrexate 55 metformin HCl 55 MOVIPREP R 55 Dementia Related Psychosis 55 POSIDUR TM 55 trabectedin 55 Seroquel XR 55 oral prodrug 55 R lenalidomide 55 Sutent sunitinib malate 54 Glybera 54 midstage clinical 54 Tekturna HCT 54 CytoFab 54 vapreotide acetate 54 Increlex TM 54 Sanvar R 54 Grants Orphan Drug 54 NOMAC E2 54 Loramyc R 54 Kit CD# positive 54 aripiprazole Abilify 54 Diamyd r 54 receptor tyrosine kinase inhibitor 54 Forsteo 54 ABILIFY ® 54 Anturol TM 54 diarrhea predominant irritable 54 application sNDA 54 Lilly Cymbalta 54 markets Gelclair R 54 Zarnestra 54 fluvoxamine maleate 54 Fingolimod 54 Ilaris 54 Jack Boland QMI 54 ELAPRASE 54 Pazopanib 54 Rifaximin 54 PrevOnco 54 Polyphenon ® E 54 promote ceftobiprole 54 Tracleer R 54 Pliaglis 54 Dapagliflozin 54 Zorbtive TM 54 EFAPROXYN 54 temsirolimus 54 selective modulator 54 R metformin Concor 54 Silenor NDA 54 Natroba 54 ZEFTERA TM 54 Exforge HCT 54 Viviant 54 Omnitrope 54 XAGRID 54 GARDASIL ® 54 Abilify aripiprazole 54 ARIXTRA R 54 ACIPHEX 54 chronic angina 54 Victoza liraglutide 54 Receives Orphan Drug 54 Altabax 54 severe gastroparesis 54 Baxter Celvapan 54 Tyzeka 54 Zometa zoledronic acid 54 Lenalidomide 54 prucalopride 54 IgG1 monoclonal antibody 54 FDA Dermatologic 54 Initiates Phase III 54 Protopic 54 LUVENIQ 54 Mylotarg 54 ruxolitinib 54 bevacizumab Avastin 54 PREOS 54 ATryn 54 Botox Botox Cosmetic 54 gadobutrol 54 docetaxel Taxotere R 54 Prexige 54 Onconase 54 Vibativ 54 Vernalis plc 54 NASDAQ Listing Qualification 54 romidepsin 54 pediatric glioma 54 brivaracetam 54 Vimpat R 54 Somatuline Autogel 54 Leukine ® 54 MEPACT 54 Fampyra 54 pitavastatin 54 alogliptin 54 Zenvia ™ 54 ketolide antibiotic 54 PNP inhibitor 54 OSI Tarceva 54 FDA APPROVES 54 Dalbavancin 54 Emselex 54 Kristalose ® lactulose 54 NerPharMa 54 Mutual Recognition Procedure 54 RAPTIVA 54 Yondelis 54 Nexavar tablets 54 R Saizen R 54 FOSAMAX PLUS D 54 Tostrex 54 Fludara 54 Vicinium TM 54 Biologics License Application 54 COMFORT II 54 DIFICID ™ 54 FDA Complete Response 54 Dr. McHutchison 54 L MTP PE 54 anidulafungin 54 Exelon rivastigmine 54 oropharyngeal candidiasis 54 Corlux 54 Periostat 54 Product Monograph 54 Pfizer Sutent 54 HepaGam B 54 Betaferon 54 severe hypersensitivity reactions 54 Psychopharmacologic Drugs Advisory 54 Sanofi Aventis Taxotere 54 XIAPEX 54 torezolid phosphate 54 cUTI 54 Focalin XR ® 54 NASDAQ CXSP announced 54 Ceplene 54 Panzem R NCD 54 RIGScan CR 54 FluLaval 54 BYDUREON 54 liprotamase 54 HPV vaccine Cervarix 54 Targretin capsules 54 Complicated Skin 54 peginesatide 54 GW# [003] 54 Ilaris ® 54 ambrisentan 54 orphan drug 54 tubulin inhibitor 54 nasal calcitonin product 54 Oncophage vitespen 54 Sodium Injection 54 aztreonam lysine 54 capsule formulation 54 Azilect ® 54 IMiDs R 54 TAXUS Element Stent System 54 velaglucerase alfa 54 Nexavar 54 nalbuphine ER 54 Argatroban 54 Belimumab 54 YERVOY 54 Hiberix 54 ankylosing spondylitis psoriatic arthritis 54 Kepivance 54 Cimzia certolizumab pegol 54 Arimoclomol 54 Vasovist TM 54 Troxatyl TM 54 Azathioprine 54 Pixantrone 54 Vimpat lacosamide 54 PDE4 inhibitor 54 palifermin 54 RhuDex 54 dual endothelin receptor antagonist 54 Zebinix R 54 Expanded Indication 54 olanzapine LAI 54 GSK Avandia 54 Zidovudine Tablets 54 TroVax ® 54 Inhalation Solution 54 ticagrelor Brilinta 54 New Drug Application 54 Intravenous Hepatitis B 54 Known hypersensitivity 54 sNDA submission 54 darifenacin 54 Teriparatide 54 SANVAR 54 Factive 54 Auxilium Pharma 54 Nasdaq ONXX today 54 PrevOnco ™ 54 Sutent sunitinib 54 pseudobulbar affect PBA 54 Vimpat ® lacosamide 54 BAY #-# 54 fidaxomicin 54 Hycamtin ® 54 Methylnaltrexone 54 Veronate 54 Votrient 54 Pegloticase 54 Investigational Compound 54 Amyvid 54 oral methylnaltrexone 54 Zelapar 54 HoFH 54 ADVEXIN p# therapy 54 orphan medicinal 54 Humenza 54 Dynastat 54 Oracea R 54 EGRIFTA ™ 54 sunitinib Sutent 54 Aciphex R 54 Arimidex anastrozole 54 APF# 54 faropenem medoxomil 53 Certolizumab pegol 53 Pruvel 53 TNF Tumor Necrosis Factor 53 Reloxin R 53 Diamyd ® 53 mertansine 53 VIBATIV 53 Roche Actemra 53 Junovan TM 53 vismodegib 53 postoperative ileus POI 53 Drug Administration FDA 53 ferumoxytol Injection 53 PRIALT 53 Abstral 53 Gilenia 53 azficel T 53 Irinotecan Hydrochloride Injection 53 Gene Therapy Advisory 53 Zegerid OTC 53 AFSSAPS 53 Ocrelizumab 53 heterozygous FH 53 tocilizumab 53 Ropinirole 53 paliperidone palmitate 53 Levetiracetam 53 satraplatin 53 ACTEMRA TM 53 QNEXA ® 53 Zavesca r 53 Veregen TM 53 somatropin 53 Fluconazole 53 Li Fraumeni Syndrome 53 antidiabetic drug 53 Lixisenatide 53 Receives Approvable Letter 53 RSR# 53 Drugs Advisory 53 idursulfase 53 Stedesa 53 Kepivance ® 53 lasofoxifene 53 IMiDs ® compound 53 vidofludimus 53 ONTAK 53 PROVENGE ® 53 FDA Advisory Panel 53 commercialize oritavancin 53 Milnacipran 53 ISTODAX 53 Pemetrexed 53 Sanofi aventis EURONEXT SAN 53 Tramadol ER 53 Release Capsules 53 Extended Release Tablets 53 VIVITROL ® 53 panitumumab Vectibix 53 Bevacizumab Avastin 53 silodosin 53 ULTRASE 53 Prestara TM 53 pirfenidone 53 SNT-MC#/idebenone 53 IV APAP 53 HER2 positive metastatic breast 53 TRISENOX R 53 granted orphan 53 Tezampanel 53 Nitoman 53 investigational hepatitis B 53 Coadministration 53 Taxotere R 53 HepaGam B TM 53 Santhera 53 Zytiga 53 Inhalation Powder 53 Alvesco ® 53 SURFAXIN 53 Aplidin 53 autologous cellular immunotherapy 53 Ceplene R 53 nonclinical studies 53 RELISTOR methylnaltrexone bromide subcutaneous 53 refractory APL 53 cutaneous T 53 ZOLINZA 53 Feraheme ® 53 Soliris eculizumab 53 TSX SHQ 53 Metabolic Drugs 53 Anturol ® 53 Regadenoson 53 Keryx Biopharma 53 BARACLUDE R 53 PhosLo 53 topical NSAID 53 Flutiform ™ 53 LymphoStat B TM 53 Files Investigational 53 Calcium Acetate 53 Risperidone 53 Levoleucovorin 53 HuMax CD4 53 DexaSite 53 branded Rectogesic 53 Ceplene ® histamine dihydrochloride 53 ATryn ® 53 NASDAQ BDSI 53 bifeprunox 53 Nasdaq OSCI 53 Dendreon Provenge 53 Paliperidone Palmitate 53 HP Acthar Gel repository 53 generation purine nucleoside 53 ENTEREG ® 53 Uplyso 53 Novartis Afinitor 53 Gamunex C 53 StaphVAX R 53 Dabigatran etexilate 53 Roflumilast 53 ANTEGREN 53 docetaxel Taxotere 53 NeutroSpec 53 Everolimus 53 Initiate Clinical Trial 53 WILEX 53 Nycomed GmbH 53 Zolinza 53 Iressa gefitinib 53 QAB# 53 Tekamlo 53 darbepoetin alfa Aranesp 53 FDA Psychopharmacologic Drugs 53 EOquin 53 SEASONIQUE 53 pulmonary arterial hypertension PAH 53 Cefprozil 53 Prestara 53 Ramelteon 53 novel oral anticoagulant 53 Pafuramidine 53 DepoDur TM 53 Cethromycin 53 Cinryze TM 53 Thrombin topical Recombinant 53 RevAssist R 53 Horizant 53 Research CDER 53 Granted Orphan Drug 53 opioid induced constipation OIC 53 Emezine R 53 fingolimod 53 Ixabepilone 53 ocular formulation 53 Approvable letter 53 Aloxi R 53 Nexavar sorafenib tablets 53 gluteal injection 53 FDA Oncologic Drug 53 eltrombopag 53 REPLAGAL 53 iclaprim 53 DNAwithPap TM Test 53 TNF blocker 53 Thelin TM 53 Krystexxa 53 www.soliris.net 53 cladribine 53 vemurafenib 53 Filgrastim 53 Neupro 53 ANDA Filing 53 cSSTI 53 Dificid 53 PGL# 53 CINTREDEKIN BESUDOTOX 53 Fabry Disease 53 mapatumumab 53 ZEVALIN ® 53 Ebixa 53 Xcytrin R 53 DPP4 53 fostamatinib 53 oral iron chelator 53 Acetavance 53 lumiracoxib 53 LEUKINE 53 Linjeta

Back to home page